Article
Protein May Predict Risk for Chemotherapy-Induced Peripheral Neuropathy
Researchers find that the protein NDRG1 may be useful in predicting paclitaxel-induced peripheral neuropathy in patients with cancer.
Researchers find that the protein NDRG1 may be useful in predicting paclitaxel-induced peripheral neuropathy in patients with cancer.
Physicians who do not have a large Medicare population or who do not bill much to Medicare Part B will get a bit more breathing room to avoid...
VIENNA – Depressed patients with a high-level occupation are more likely to be treatment resistant.
A significant percentage of patients who meet criteria for palliative care consultations do not receive a consult during their hospital stay,...
Fluid administration of at least 1 L did not increase the incidence of acute respiratory or heart failure in severe sepsis, and actually seemed to...
The timing of endoscopy may make the difference between life and death in sicker patients with peptic ulcer bleeding, according to an analysis of...
WASHINGTON, DC
The US Food and Drug Administration (FDA) has approved use of the PreciseType HEA test to screen blood donors for sickle cell trait (SCT). The...
The US Food and Drug Administration (FDA) has granted orphan drug designation to TLC178 for the treatment of cutaneous T-cell lymphoma (CTCL)....